Teladoc Stock is a hot topic. If you are considering buying Teladoc stock, there are a few things to consider before making a decision. We have collected some basic information about the company and its current financial situation so that you can make an informed purchase.
What is Teladoc?
Teladoc (TDOC) is a website that provides online medical consultation and diagnosis. This company was founded in 2008 and recently went public on the New York Stock Exchange. The site aims to replace actual doctors with other healthcare professionals who can help diagnose patients or provide general advice over the phone. Instead of entering the office and waiting for hours to see a doctor, users can log in through a computer and discuss their health issues with someone online.
Annual income generated by Teladoc
Teladoc was founded by Jason Gorevic in 2008 to provide a way for people who need to see a doctor but cannot see a doctor due to time constraints.
Currently, the consultation fee for each visit is US$75, and follow-up is free. The company plans to add more specialties to build their medical expertise. Teladoc currently serves approximately 1 million people each year and has an annual revenue of approximately US$2 billion.
Current price and performance of Teladoc stock
TDOC shares closed at 137.79 on Friday, October 22, and fell 3% on that day. The number of outstanding shares is 15946 million shares. In the past 52 weeks, the stock exchange has fluctuated between 120.67 and 308.
At present, few analysts rate Teladoc stock as buy; 1 rate it as sold; 3 rate it as hold; 4 investors are advised not to buy or sell Teladoc stock. The consensus recommendation is to maintain the stock in the range of US$137.36 to US$142.21 in the next few months to obtain a better exchange rate.
Latest news on Teladoc stock
Like any listed company, TDOC's stock price may be affected by many factors. Investors are advised to monitor TDOC news at least 4-5 times a week and make decisions based on TDOC news, especially when market volatility or major developments in Teladoc stock occur before earnings reports.
In addition, investors should pay attention to executive comments in conference calls and speeches, which can better understand how Wall Street views this latest move by Teladoc.
Is it worth a try to acquire Teladoc shares?
In short, at the moment, buying Teladoc stock does not seem to be a good bet. Due to some early negative news reports from competitors that its products are inferior to TDOC online services, the stock has been underperforming since its initial listing.
However, bullish investors may feel more confident in this discounted price of Teladoc stock. Time will tell whether it will continue to fall or eventually rebound, but either way, it is destined to be a roller coaster.
If you are considering buying Teladoc stock and want to learn more about this telemedicine company, please check their official website: www.teladoc.com.